| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/15/2007 | US20070036785 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/15/2007 | DE10242062B4 Hydrierte kondensierte Palatinose, Verfahren zu deren Herstellung und deren Verwendung Hydrogenated condensed palatinose, processes for their preparation and their use |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752457A1 Fused heterocyclic compound |
| 02/14/2007 | EP1752456A1 Corneal perception recovery drug containing amide compound |
| 02/14/2007 | EP1752452A1 Propane-1,3-dione derivative or its salt |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1752146A1 Therapeutic agent for diabetes |
| 02/14/2007 | EP1751183A2 Fas associated factor 1 |
| 02/14/2007 | EP1751181A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS |
| 02/14/2007 | EP1750809A1 Citrus fruit skin extract for angiogenesis promotion |
| 02/14/2007 | EP1750748A1 Use of the foamy virus bet protein for inactivating apobec |
| 02/14/2007 | EP1750736A1 Uses for the extract of a plant of the family asclepiadaceae |
| 02/14/2007 | EP1750705A1 Selective serotonin receptor inverse agonists as therapeutics for disease |
| 02/14/2007 | EP1680128B1 Myo-inositol hexaphosphate for topical use |
| 02/14/2007 | EP1536777B1 Use of nf-kappa b inhibitors for the treatment of mastitis |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1507514B1 Controlled release compositions of estradiol metabolites |
| 02/14/2007 | EP1496909B1 Combination therapy for the treatment of cancer |
| 02/14/2007 | EP1438045B1 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake |
| 02/14/2007 | EP1435943B1 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug for treating dyskinesia |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1414409B1 Stabilized oral suspension formulation |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1392355B1 Use of proteasome inhibitors to treat dry eye disorders |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1368336B9 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1315750B1 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP1294715B1 Quinazoline ditosylate salt compounds |
| 02/14/2007 | EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 02/14/2007 | EP1267857B1 In vitro use of astaxanthin for pretreatment of cells prior to UV-exposure to inhibit the activation of NF-kB |
| 02/14/2007 | EP1260590B1 Method of screening substance specifically inhibiting non-mevalonate pathway |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP1242452B1 Chimeric natriuretic peptides |
| 02/14/2007 | EP1200458B1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/14/2007 | EP1171144B1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
| 02/14/2007 | EP1169069B1 Use of three-dimensional stromal tissue for the treatment of ischemic tissue |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 02/14/2007 | EP1035780B1 Method for purifying heat shock peptides complexes |
| 02/14/2007 | EP0999845B1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914335A Antisense oligonucleotide modulation of STAT3 expression |
| 02/14/2007 | CN1914194A Therapeutic agent for vasospasm accompanying bypass operation |
| 02/14/2007 | CN1914168A Peptidyl arginine deiminase type IV inhibitor |
| 02/14/2007 | CN1913916A Use of factor VIIA for treating trauma |
| 02/14/2007 | CN1911960A Chlamydia protein, gene sequence and uses thereof |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911918A Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911417A Traditional Chinese medicine prescription for removing tragomaschalia and its prepn. method |
| 02/14/2007 | CN1911332A Medicine composition for treating infantile thirst low fever |
| 02/14/2007 | CN1911304A Traditional Chinese medicine composition for treating liver diseases and muscle disease |
| 02/14/2007 | CN1911257A Extractive of ginkgo tree leaves, prepn. method and application thereof |
| 02/14/2007 | CN1911236A Application of doxycycline ad medicine for promoting cell proliferation |
| 02/14/2007 | CN1911227A Novel prepn. of levomisole, and its new use |
| 02/14/2007 | CN1911223A Prepn. of mebendazole for treating adenoid hypertrophy |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1300126C Application of 3-hydroxyphenyl phthale compound in preparing culicifuge |
| 02/14/2007 | CN1300116C 1H-indazole compound |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2007 | CN1300111C Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/14/2007 | CN1299765C Thymosin peptide oral tablet and its preparation method |
| 02/14/2007 | CN1299711C Danlu traditional Chinese medicine tablet for treating lumbar vertebral canal stenosis and preparing method thereof |
| 02/14/2007 | CN1299689C Application of alendronate in preparation of drug for inhibitting bone resorption |
| 02/14/2007 | CN1299682C Use of pyrazoline derivatives in preparation of medicament for prevention and/or treatment of proliferative cell diseases |
| 02/14/2007 | CN1299679C Preventive or remedy for bedsore |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/14/2007 | CN1299676C Anti-anoxia medicinal composition |
| 02/13/2007 | US7176327 Water soluble, biologically inert Pt(IV) compounds which can be converted to cytotoxic Pt(II) species by photoactivation; reduced side effect anticancer drugs |
| 02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
| 02/13/2007 | US7176312 Kinase inhibitor scaffolds and methods for their preparation |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase |
| 02/13/2007 | US7176240 Such as 5-fluoro-2-propylpentanoic acid for improving GABA (gamma-aminobutyric acid) receptor responses; treatment of neurodegenerative diseases |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176224 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists |
| 02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
| 02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |